期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

放射治疗对乳腺导管原位癌保乳术后复发率的影响一项基于随机对照试验的Meta分析 被引量：3

Effect of Adjuvant Radiation after Breast Conserving Surgery on the Risk of Recurrence for Patients with Ductal Carcinoma In Situ of the Breast:A Meta Analysis Based on Randomized Controlled Trials
在线阅读 下载PDF
导出
摘要 目的:用Meta分析方法评价放射治疗能否降低乳腺导管原位癌(DCIS)保乳术后的复发率方法:计算机检索PubMed、EMBASE、CochraneLibrarlv、中国生物医学文献数据库、中文科技期刊全文数据库、中国期刊全文数据库、万方数据库,手工检索搜集有关放疗辅助治疗DCIS的随机对照试验,用RevMan5.0软件进行统计分析。结果:纳入4篇随机对照试验共计2701例乳腺癌患者,Meta分析结果显示,保乳术后联合放射治疗与单纯手术比较,乳腺导管原位癌复发率较低,两者相比差异有统计学意义(RR=0.45,95%CI:037～0.55)亚组分析均提示辅助放疗可以降低其复发率。结论:DCIS患者保乳术后放射治疗可以降低其复发率,高危患者可能受益更多。 Objective： This study aims to determine whether adjuvant radiotherapy could reduce the recurrence of ductal carcinoma in situ （ DCIS ）. Methods： PubMed, Embase, Cochrane Library, Chinese biomedical literature database, Chinese Scientific Journal full-text database, Chinese Journal full-text database, WANGFANG, and the bibliographies of retrieved articles for randomized controlled trials were searched to compare the risk of recurrence in patients treated with and without radiotherapy. The data were analyzed using Review Manager 5.0. Results： Four randomized controlled trials in 2,701 participants were included in this study. The results of the meta analysis showed that radiotherapy following breast conserving surgery significantly affected the risk of recurrence in DCIS treatment compared with surgery alone. All the analyzed subgroups benefited from the application of radiotherapy. Conclusion： Adjuvant radiotherapy can reduce the risk of recurrence in DCIS treatment, from which participants with high risk may benefit more than those with low risk.
作者 赵成茂 张宝亮 赵成鹏 马建萍 马贞秀
机构地区 青海省第五人民医院乳腺中心
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第11期772-776,共5页 Chinese Journal of Clinical Oncology
关键词 放射治疗 乳腺导管原位癌 保乳手术 META分析 Radiotherapy Ductal carcinoma in situ Breast conserving surgery Meta analysis
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1Harris JR, Lippman ME, Veronesi U, et al. Breast cancer(2)[J].N EnglJ Med, 1992, 327(6): 390-398.
  • 2Burstein HJ, Polyak K, WongJS, et al. Ductal carcinoma in situ of the breast[J].N EnglJ Med, 2004, 350(14): 1430-1441.
  • 3Levine M. Cfinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update)[J]. CMAJ, 2001, 164(2): 213.
  • 4Solin LJ, Fourquet A, Vicini FA, et al. Salvage treatment for local re- currence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast[J]. Cancer, 2001, 91(6): 1090-1097.
  • 5The management of ductal carcinoma in situ(DCIS). The SteeringCommittee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists[J]. CMAJ, 1998, 158 Suppl 3: $27-34.
  • 6HoughtonJ, George WD, GuzickJ, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled triM[J].Lancet, 2003, 362(9378): 95-109.
  • 7Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radio- therapy in women with locally excised ductal carcinoma in situ: long-term results from the LrK/ANZ DCIS trial[J]. Lancet Oncol, 2011, 12(1): 21-29.
  • 8Fisher B, DignamJ, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: mdings from National Surgical Adjuvant Breast and Bowel Project B-17[J].J Clin Oncol, 1998, 16(2): 441-452.
  • 9Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-sire: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase Ill trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group [J]. ] Clin Oncol, 2006, 24(21): 3381-3387.
  • 10Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: Radiothera-py after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammogra- phy screening[J]. Acta Oncol, 2006, 45(5): 536--543.

共引文献5

同被引文献22

  • 1邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
  • 2Brinton LA, Sherman ME, Carreon JD, et al. Recent trends in breast cancer among younger women in the United States[J]. J Natl Cancer Inst, 2008, 100(22): 1643-1648.
  • 3Dunne C, Burke JP, Morrow M, et al. Effect of margin status on local recurrence aider breast conservation and radiation therapy for ductal carcinoma in situ[J]. J Clin Ontol, 2009, 27(10): 1615-1620.
  • 4Cuzick J, Sestak I, Pindcr SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial [ J ]. Lancet Oncol,2011,12(1):21-29.
  • 5Zavagno G, Carcoforo P, Marconato R, et al. Role of axillary sentinel lymph node biopsy in patients pure ductal carcinoma in situ of the breast[J]. BMC Cancer,2005,5:28.
  • 6Ko BS, Lim WS, Kim HI, et al. Risk factor for axillary lymph node metastases in microinvasive breast cancer[J]. Ann Surg Oncol, 2012, 19(1) :212-216.
  • 7Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. [J]. Cancer, 1998, 82(12) :2382-3290.
  • 8Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006[J]. CA Cancer J Clin, 2006, 56(3) :168- 183.
  • 9Castellana B, Escuin D, Peir6 G, ct al. ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas [J]. JCancer, 2012, 3:175-183.
  • 10Volinia S, Galasso M, Sana ME, et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA [J]. Proc Natl Acad Sci U S A, 2012, 109(8) :3024-3029.

引证文献3

二级引证文献3

中国肿瘤临床
2012年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部